Thompson Jaye - Insider Non-Derivative Transactions at Greenwich LifeSciences, Inc. (GLSI) - (SEC)

Updated on December 12, 2024.

According to recent SEC insider information filed on Aug 12, 2024, Thompson Jaye's relationship to Greenwich LifeSciences, Inc. (GLSI) is Officer (VP Clinical Reg Affairs), and currently has 263,148 shares of Common Stock.

The chart below shows the number of shares owned, and the table shows the recent insider transactions.

You can see similar information for other GLSI insiders.

Data Source: SEC.
Thompson Jaye - Insider Non-Derivative Transactions of GLSI Common Stock
Thompson Jaye - Insider Non-Derivative Transactions at GLSI
Items per page:
0 of 0
Date Transaction No. of Shares Price Per Share Shares Owned After Transactions
Aug 13, 2024 P -- (Common Stock) 800 13.85 263148
Aug 3, 2024 P -- (Common Stock) 1000 15.15 262348
Jul 19, 2024 P -- (Common Stock) 1000 16 261348
Oct 28, 2023 P -- (Common Stock) 500 8.57 260348
Sep 27, 2023 P -- (Common Stock) 600 8.71 259848
Jul 14, 2023 P -- (Common Stock) 250 9.49 259248
Apr 29, 2023 P -- (Common Stock) 250 11.22 258998
Apr 12, 2023 P -- (Common Stock) 1000 11.87 258745
Mar 16, 2023 P -- (Common Stock) 250 12.71 257745
Feb 25, 2023 P -- (Common Stock) 250 15.4 257495
Feb 4, 2023 P -- (Common Stock) 250 20.84 257245
Jan 28, 2023 P -- (Common Stock) 250 19.2 256995
Jan 14, 2023 P -- (Common Stock) 250 16.5 256745